HPV
Showing 4 of 4 results
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
Published pre-clinical results show fenofibrate restores function of key tumor suppressor gene in these cancers | Innovations in Cancer February 2025
Navigating the Complex Mechanisms of HPV+ Head and Neck Cancers
Quintin Pan, PhD, explores the surge of HPV+ related head and neck cancers sparking the need for innovative treatment solutions.
Team at UH Seidman Cancer Center Identifies Robust Immune Biomarker Predicting Survival in HPV-positive Head and Neck Squamous Cell Carcinoma
Findings can guide which patients are best candidates for de-escalation strategies - Innovations in Cancer | March 2021
Taking the Helm
A conversation with Ted Teknos, MD, new President of UH Seidman Cancer Center Innovations in Cancer - Winter 2018 TED TEKNOS, MD Q: What are the most important trends in cancer care right now and how is UH Seidman Cancer Center positioned to...